Our aim was to determine country-specific attitudes and perceptions of patients with genital
warts and to understand the psychosexual impact of the disease and its treatment. We used …

The objective of the study was to determine the cost implications of patterns of treatment for
patients with external genital warts. A retrospective case note review was carried out at six …

Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …

To assess gender-specific impact of genital warts on health-related quality of life (HRQoL),
and to explore to what extent sexual characteristics and clinical symptoms influenced the …

Background: Genital warts (condyloma acuminatum) remain one of the most commonly
reported sexually transmitted infections (STI) worldwide. Most genital warts are caused by …

Background Genital warts, which are caused by infection with human papillomavirus (HPV),
are one of the most common sexually transmitted diseases in Europe. Although genital warts …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …

Human papilloma virus (hpv) is one of the most common sexually transmitted infections. It is
estimated that 75% of sexually active individuals will have HPV-related infection in their …